LGND Ligand Pharmaceuticals Incorporated - Common Stock
$288,74
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 7, 2026
Zakres 52 tyg.
$152–$327
78% of range
Ocena Analityków
BUY
15 analysts
Cena Docelowa
$344
+19% upside
P/E (TTM)
47.7
ROE
13.5%
Marża Zysku Netto
46.4%
LGND Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$288.74
Kapitalizacja Rynkowa
$5.78B
P/E (TTM)
47.7
EPS (TTM)
$6.13
Przychody (TTM)
$268M
Stopa dywidendy
—
ROE
13.5%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$152 – $327
LGND Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$268M
2016-12-31
→
2025-12-31
EPS
$6.13
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$49M
2016-12-31
→
2025-12-31
Marże
46.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
LGND
Mediana porównawcza
P/E (TTM)
47.7
38.7
P/S (TTM)
21.6
9.5
P/B
5.7
3.8
Price / FCF (Cena / FCF)
118.2
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
LGND
Mediana porównawcza
Operating Margin (Marża Operacyjna)
15.3%
—
Net Profit Margin (Marża Zysku Netto)
46.4%
15.3%
ROA
10.0%
-6.4%
ROE
13.5%
-16.8%
ROIC
3.2%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
LGND
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
22.2
12.8
Quick Ratio (Wskaźnik Szybkości)
21.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
LGND
Mediana porównawcza
Revenue YoY (Przychody R/R)
60.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
11.0%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
10.4%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
LGND
Mediana porównawcza
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
—
Wskaźnik Wypłaty Dywidendy
—
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 3 kwietnia 2007 | $9,3575 |
LGND Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
15 analityków
- Mocne kupno 6 40,0%
- Kup 8 53,3%
- Trzymaj 1 6,7%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
10 analityków · 2026-08-13
Mediana
$347.50
Teraz
$288.74
Niski
$247.00
Wysoki
$388.00
Średni cel
$347.50
+20,4%
Średnia cel
$343.80
+19,1%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.34%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $2.37 | $1.88 | 0.49% |
| 31 marca 2026 | $1.63 | $1.85 | -0.22% |
| 31 grudnia 2025 | $2.02 | $1.59 | 0.43% |
| 30 września 2025 | $3.09 | $1.96 | 1.1% |
| 30 czerwca 2025 | $1.60 | $1.45 | 0.15% |
| 31 marca 2025 | $1.33 | $1.24 | 0.09% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | — |
| BLTE | — | — | — | — | — | — |
| DFTX | $1.32B | -6.5 | 212.0% | — | -71.0% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
| MANE | — | — | — | — | 82.6% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $167M | $131M | $196M | $242M | $164M | $120M | $251M | $141M | $109M | $72M | $65M | |
| Cost of Revenue | · | · | · | · | · | · | · | $6M | $5M | $6M | $6M | $9M | |
| R&D Expense | $81M | $21M | $25M | $36M | $32M | $41M | $56M | $28M | $27M | $21M | $11M | $10M | |
| SG&A Expense | $92M | $79M | $53M | $70M | $47M | $60M | $42M | $38M | $29M | $28M | $25M | $23M | |
| Operating Income | $41M | $-23M | $12M | $3M | $104M | $38M | $807M | $164M | $68M | $44M | $27M | $20M | |
| Interest Expense | · | · | $656.0K | $2M | $20M | $27M | $36M | $48M | $13M | $13M | · | $5M | |
| Interest Income | $14M | $8M | $8M | $2M | $886.0K | $8M | $28M | $14M | $2M | · | · | · | |
| Other Non-op | $-89.0K | $-20M | $-2M | $4M | $-8M | $62.0K | $-4M | $-6M | $3M | $-615.0K | $2M | $2M | |
| Pretax Income | $159M | $3M | $64M | $36M | $72M | $1M | $797M | $173M | $57M | $8M | $35M | $11M | |
| Income Tax | $35M | $7M | $10M | $41M | $-4M | $-5M | $167M | $30M | $45M | $10M | $-192M | $410.0K | |
| Net Income | $124M | $-4M | $52M | $-33M | $57M | $-3M | $629M | $143M | $13M | $-2M | $230M | $12M | |
| EPS (Basic) | $6.44 | $-0.22 | $3.02 | $-1.98 | $3.44 | $-0.18 | $33.13 | $6.77 | $0.60 | $-0.08 | $11.61 | $0.59 | |
| EPS (Diluted) | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 | $-0.18 | $31.85 | $5.96 | $0.53 | $-0.08 | $10.83 | $0.56 | |
| Shares (Basic) | 19,338,000 | 18,290,000 | 17,298,000 | 16,868,000 | 16,630,000 | 16,185,000 | 18,995,000 | 21,160,000 | 21,032,000 | 20,831,000 | 19,790,000 | 20,419,000 | |
| Shares (Diluted) | 20,294,000 | 18,290,000 | 17,757,000 | 16,868,000 | 17,246,000 | 16,825,000 | 19,757,000 | 24,067,000 | 23,481,000 | 20,831,000 | 21,228,000 | 21,433,000 | |
| EBITDA | $75M | $13M | $48M | $55M | $130M | $52M | $825M | $178M | $80M | $55M | $30M | $22M |
Bilans 30
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $175M | $72M | $23M | $45M | $20M | $48M | $72M | $117M | $21M | $19M | $97M | $160M | |
| Short-term Investments | $559M | $184M | $147M | $167M | $322M | $364M | $998M | $601M | $181M | $122M | $103M | $7M | |
| Receivables | $60M | $38M | $33M | $30M | $85M | $57M | $30M | $56M | $26M | $15M | $6M | $13M | |
| Inventory | $9M | $14M | $24M | $13M | $27M | $26M | $7M | $7M | $4M | $2M | $2M | $269.0K | |
| Prepaid Expense | · | $2M | $1M | $1M | · | · | · | · | $1M | $2M | $1M | $835.0K | |
| Other Current Assets | $6M | $9M | $3M | $2M | $4M | $4M | $5M | $11M | $2M | $2M | $2M | $2M | |
| Current Assets | $832M | $332M | $237M | $264M | $465M | $501M | $1.12B | $871M | $237M | $163M | $215M | $185M | |
| PP&E (Net) | $4M | $15M | $16M | $12M | $13M | $13M | $7M | $5M | $4M | $2M | $372.0K | $486.0K | |
| PP&E (Gross) | $10M | $23M | $22M | $23M | $29M | $20M | $10M | $8M | $6M | $3M | $3M | $3M | |
| Accum. Depreciation | $7M | $8M | $7M | $10M | $9M | $6M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Goodwill | $102M | $105M | $103M | $0 | $106M | $190M | $95M | $87M | $86M | $72M | $12M | $12M | |
| Intangibles | $225M | $267M | $300M | $342M | $377M | $595M | $210M | $220M | $229M | $205M | $48M | $51M | |
| Other Non-current Assets | $13M | $32M | $6M | $2M | $1M | $4M | $2M | $471.0K | $5M | $2M | $27.0K | $207.0K | |
| Total Assets | $1.56B | $942M | $787M | $763M | $1.30B | $1.36B | $1.49B | $1.26B | $671M | $602M | $503M | $258M | |
| Accounts Payable | $3M | $5M | $2M | $5M | $8M | $4M | $2M | $4M | $2M | $3M | $4M | $8M | |
| Accrued Liabilities | $31M | $28M | $12M | $16M | $18M | $19M | $9M | $19M | $7M | $6M | $5M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $225M | $213M | $202M | $334.0K | |
| Current Liabilities | $37M | $37M | $17M | $99M | $42M | $100M | $17M | $82M | $239M | $227M | $223M | $23M | |
| Capital Leases | $4M | $6M | $6M | $10M | $2M | $6M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $36M | $33M | $32M | $31M | $31M | $65M | $33M | $0 | · | · | · | $3M | |
| Other Non-current Liabilities | $17M | $30M | $28M | $28M | $22M | $31M | $22M | $951.0K | $4M | $687.0K | $297.0K | $770.0K | |
| Total Liabilities | $543M | $111M | $86M | $165M | $476M | $653M | $728M | $700M | $252M | $231M | $226M | $234M | |
| Total Debt | · | · | · | · | · | · | · | · | $225M | $213M | $202M | $334.0K | |
| Common Stock | $20.0K | $20.0K | $18.0K | $17.0K | $17.0K | $16.0K | $17.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | |
| Paid-in Capital | $401M | $337M | $199M | $148M | $373M | $318M | $367M | $791M | $798M | $770M | $662M | $681M | |
| Retained Earnings | $608M | $499M | $503M | $451M | $449M | $392M | $400M | $-229M | $-401M | $-431M | $-429M | $-659M | |
| AOCI | $8M | $-6M | $-817.0K | $-984.0K | $-917.0K | $-801.0K | $-216.0K | $-1M | $2M | $3M | $5M | $5M | |
| Stockholders' Equity | $1.02B | $830M | $701M | $597M | $821M | $710M | $767M | $561M | $400M | $341M | $237M | $26M | |
| Liabilities + Equity | $1.56B | $942M | $787M | $763M | $1.30B | $1.36B | $1.49B | $1.26B | $671M | $602M | $503M | $258M | |
| Shares Outstanding | 19,774,000 | 19,106,000 | 17,556,000 | 16,951,000 | 16,767,000 | 16,080,000 | 16,823,000 | 20,766,000 | 21,148,665 | 20,909,301 | 19,949,012 | 19,575,150 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34M | $35M | $37M | $52M | $51M | $26M | $18M | $13M | $11M | $11M | $3M | $3M | |
| Stock-based Comp | $47M | $41M | $26M | $60M | $39M | $31M | $25M | $21M | $25M | $19M | $12M | $11M | |
| Deferred Tax | $22M | $-16M | $10M | $30M | $-5M | $-17M | $75M | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | $47M | $23M | $17M | $16M | $12M | $11M | $2M | $2M | |
| Other Non-cash | $-178M | $41M | $-75M | $29M | $-60M | $1M | $-702M | $15M | $44M | $34M | $-203M | $-5M | |
| Operating Cash Flow | $49M | $97M | $50M | $138M | $79M | $55M | $-29M | $194M | $89M | $61M | $42M | $21M | |
| CapEx | $452.0K | $2M | $4M | $18M | $9M | $4M | $3M | $887.0K | $2M | $2M | $93.0K | $6.0K | |
| Investing Cash Flow | $-377M | $-144M | $-12M | $164M | $31M | $232M | $467M | $-423M | $-79M | $-134M | $-113M | $-2M | |
| Net Debt Issued | $0 | $0 | $-77M | $-261M | $-156M | $-222M | $-27M | $-218M | · | $0 | $0 | $-9M | |
| Stock Issued | $0 | $37M | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $15M | $0 | $0 | $0 | $0 | $78M | $453M | $123M | $2M | $4M | $489.0K | $68M | |
| Net Stock Activity | $-15M | $37M | · | $0 | $0 | $-78M | $-453M | $-123M | $-2M | $-4M | $-489.0K | $-68M | |
| Financing Cash Flow | $428M | $97M | $-60M | $-276M | $-138M | $-311M | $-485M | $329M | $-8M | $-5M | $8M | $130M | |
| Net Change in Cash | $103M | $49M | $-22M | $25M | · | · | · | · | $2M | $-79M | $-63M | $149M | |
| Taxes Paid | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $49M | $95M | $46M | $120M | $70M | $50M | $-32M | $193M | $91M | $61M | $42M | $21M | |
| Levered FCF | · | · | $46M | $120M | $46M | $42M | $-60M | $153M | · | · | · | $16M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.3% | -13.5% | 9.1% | 1.6% | 28.5% | 13.9% | 671.0% | 65.1% | 48.2% | 40.3% | 38.0% | 30.4% | |
| Net Margin | 46.4% | -2.4% | 39.7% | -17.0% | 20.6% | -1.6% | 523.2% | 57.0% | 8.9% | -1.5% | 319.6% | 18.6% | |
| Pretax Margin | 59.3% | 1.5% | 48.5% | 18.4% | 17.1% | -5.7% | 662.3% | 68.9% | 40.6% | 7.3% | 49.1% | 17.5% | |
| EBITDA Margin | 27.9% | 7.6% | 36.9% | 27.8% | 46.9% | 27.7% | 686.2% | 71.0% | 56.5% | 50.6% | 41.7% | 34.5% | |
| ROA | 10.0% | -0.47% | 6.7% | -3.2% | 4.3% | -0.21% | 45.7% | 14.8% | 2.0% | -0.30% | · | 6.6% | |
| ROE | 13.5% | -0.48% | 7.6% | -4.7% | 7.0% | -0.42% | 77.8% | 22.7% | 3.4% | -0.57% | · | 31.7% | |
| ROIC | 3.2% | 4.4% | 1.4% | -0.07% | 11.6% | 1.0% | 83.1% | 24.1% | 2.4% | -2.4% | 87.1% | 71.0% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.2 | 8.9 | 14.1 | 2.7 | 11.2 | 5.0 | 66.1 | 10.6 | 1.0 | 0.7 | · | 8.1 | |
| Quick Ratio | 21.2 | 7.9 | 12.1 | 2.5 | 10.2 | 4.7 | 61.3 | 9.4 | 1.0 | 0.7 | · | 7.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.6 | · | 0.0 | |
| Interest Coverage | · | · | 18.2 | 1.7 | 4.0 | 0.9 | 22.6 | 3.4 | · | · | · | 4.0 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | · | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | 1.1 | 1.7 | 3.1 | · | 11.0 | |
| Receivables Turnover | 5.5 | 4.7 | 4.1 | 3.4 | 3.9 | 4.3 | 2.8 | 6.2 | 7.0 | 10.4 | · | 8.7 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.4% | 27.3% | -33.1% | -18.8% | 47.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.0% | -11.6% | -7.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.4% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $268M | $167M | $131M | $196M | $242M | $164M | $120M | $251M | $141M | $109M | $72M | $65M | |
| Net Income TTM | $124M | $-4M | $52M | $-33M | $57M | $-3M | $629M | $143M | $13M | $-2M | $230M | $12M | |
| Market Cap | $3.74B | $2.05B | $1.25B | $1.13B | $1.62B | $998M | $1.09B | $1.76B | $1.81B | $1.33B | · | $650M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $1.83B | $1.40B | · | $483M | |
| P/E | 30.8 | -487.0 | 24.3 | -33.7 | 29.1 | -344.7 | 2.0 | 14.2 | 161.2 | -792.3 | 6.2 | 59.3 | |
| P/S | 13.9 | 12.2 | 9.5 | 5.8 | 6.7 | 6.1 | 9.1 | 7.0 | 12.8 | 12.2 | · | 10.1 | |
| P/B | 3.7 | 2.5 | 1.8 | 1.9 | 2.0 | 1.4 | 1.4 | 3.1 | 4.5 | 3.9 | · | 24.7 | |
| P / Tangible Book | 5.4 | 4.5 | 4.2 | 4.4 | 4.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | 75.7 | 21.1 | 25.3 | 8.2 | 20.5 | 18.3 | -37.3 | 9.1 | 19.3 | 21.0 | · | 31.6 | |
| P / FCF | 76.4 | 21.5 | 27.2 | 9.4 | 23.1 | 19.9 | -34.3 | 9.1 | 19.8 | 21.7 | · | 31.6 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 22.9 | 25.3 | · | 21.7 | |
| EV / FCF | · | · | · | · | · | · | · | · | 20.0 | 22.8 | · | 23.5 | |
| EV / Revenue | · | · | · | · | · | · | · | · | 13.0 | 12.8 | · | 7.5 | |
| Earnings Yield | 3.2% | -0.21% | 4.1% | -3.0% | 3.4% | -0.29% | 49.0% | 7.0% | 0.62% | -0.13% | 16.0% | 1.7% |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $64M | $52M | $60M | $115M | $48M | $45M | $43M | $52M | $42M | $31M | $28M | $33M | $26M | $44M | $50M | $59M | |
| R&D Expense | $15M | $2M | $4M | $21M | $7M | $50M | $4M | $6M | $5M | $6M | $5M | $6M | $7M | $7M | $9M | $9M | |
| SG&A Expense | $29M | $21M | $25M | $28M | $20M | $19M | $26M | $24M | $18M | $11M | $16M | $15M | $11M | $11M | $31M | $15M | |
| Operating Income | $9M | $17M | $14M | $55M | $8M | $-36M | $-10M | $3M | $-19M | $3M | $-3M | $3M | $-2M | $14M | $-20M | $12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141.0K | · | $1.0K | $284.0K | $240.0K | · | $332.0K | |
| Interest Income | $7M | $7M | $6M | $4M | $2M | $2M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $591.0K | |
| Other Non-op | $3M | $-1M | $1M | $-443.0K | $1M | $-3M | $25M | $-9M | $-34M | $-2M | $3M | $-4M | $-873.0K | $603.0K | $-793.0K | $677.0K | |
| Pretax Income | $64M | $-24M | $57M | $141M | $11M | $-50M | $-39M | $-6M | $-65M | $113M | $17M | $-12M | $3M | $56M | $24M | $12M | |
| Income Tax | $16M | $-11M | $12M | $24M | $6M | $-8M | $-8M | $833.0K | $-13M | $27M | $-1M | $-2M | $881.0K | $12M | $39M | $3M | |
| Net Income | $49M | $-13M | $45M | $117M | $5M | $-42M | $-31M | $-7M | $-52M | $86M | $18M | $-10M | $2M | $42M | $-17M | $404.0K | |
| EPS (Basic) | $2.42 | $-0.67 | $2.41 | $5.99 | $0.25 | $-2.21 | $-1.81 | $-0.39 | $-2.88 | $4.86 | $1.02 | $-0.59 | $0.13 | $2.46 | $-1.04 | $0.02 | |
| EPS (Diluted) | $2.22 | $-0.67 | $2.42 | $5.68 | $0.24 | $-2.21 | $-1.70 | $-0.39 | $-2.88 | $4.75 | $1.07 | $-0.59 | $0.13 | $2.33 | $-1.04 | $0.02 | |
| Shares (Basic) | 20,063,000 | 19,883,000 | -38,758,000 | 19,578,000 | 19,327,000 | 19,191,000 | -35,889,000 | 18,419,000 | 18,028,000 | 17,732,000 | -34,421,000 | 17,380,000 | 17,276,000 | 17,063,000 | -33,712,000 | 16,888,000 | |
| Shares (Diluted) | 21,837,000 | 19,883,000 | -39,452,000 | 20,629,000 | 19,926,000 | 19,191,000 | -36,279,000 | 18,419,000 | 18,028,000 | 18,122,000 | -35,327,000 | 17,380,000 | 17,730,000 | 17,974,000 | -34,146,000 | 17,132,000 | |
| EBITDA | $9M | $26M | · | $55M | $8M | $-27M | · | $3M | $-19M | $12M | · | $3M | $-2M | $24M | · | $636.0K |
Bilans 29
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $115M | $175M | $139M | $68M | $48M | $72M | $64M | $18M | $50M | · | $19M | $28M | $89M | · | $4M | |
| Short-term Investments | $351M | $664M | $559M | $525M | $177M | $161M | $184M | $156M | $209M | $260M | · | $171M | $191M | $194M | · | $117M | |
| Receivables | $67M | $53M | $60M | $58M | $41M | $38M | $38M | $34M | $37M | $28M | · | $36M | $28M | $29M | · | $65M | |
| Inventory | $10M | $13M | $9M | $12M | $15M | $15M | $14M | $17M | $19M | $21M | · | $25M | $27M | $14M | · | $22M | |
| Prepaid Expense | · | · | · | · | · | · | · | $2M | $2M | $1M | · | · | · | · | · | · | |
| Other Current Assets | $6M | $6M | $6M | $7M | $5M | $13M | $9M | $20M | $7M | $7M | · | $2M | $3M | $2M | · | $11M | |
| Current Assets | $1.46B | $865M | $832M | $754M | $353M | $309M | $332M | $309M | $312M | $369M | · | $254M | $277M | $328M | · | $220M | |
| PP&E (Net) | $3M | $3M | $4M | $3M | $4M | $4M | $15M | $15M | $15M | $15M | · | $16M | $11M | $12M | · | $33M | |
| PP&E (Gross) | · | · | $10M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $102M | $102M | $102M | $102M | $102M | $102M | $105M | $105M | $105M | $105M | · | $104M | $106M | $106M | $0 | $181M | |
| Intangibles | $209M | $217M | $225M | $234M | $250M | $258M | $267M | $275M | $283M | $291M | · | $315M | $325M | $334M | · | $517M | |
| Other Non-current Assets | $12M | $13M | $13M | $3M | $9M | $8M | $32M | $8M | $12M | $11M | · | $8M | $4M | $5M | · | $6M | |
| Total Assets | $2.19B | $1.53B | $1.56B | $1.48B | $949M | $905M | $942M | $955M | $866M | $914M | · | $769M | $758M | $811M | · | $1.05B | |
| Accounts Payable | $9M | $5M | $3M | $4M | $9M | $5M | $5M | $5M | $2M | $2M | · | $2M | $10M | $6M | · | $16M | |
| Accrued Liabilities | $32M | $32M | $31M | $24M | $17M | $24M | $28M | $16M | $12M | $12M | · | $11M | $7M | $15M | · | $19M | |
| Current Liabilities | $47M | $41M | $37M | $31M | $65M | $59M | $37M | $25M | $19M | $18M | · | $16M | $29M | $99M | · | $135M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | · | $6M | $11M | $11M | · | $35M | |
| Deferred Tax | $22M | $23M | $36M | $23M | $32M | $29M | $33M | $46M | $30M | $51M | · | $33M | $28M | $30M | · | $30M | |
| Other Non-current Liabilities | $17M | $17M | $17M | $20M | $14M | $14M | $30M | $30M | $29M | $28M | · | $44M | $22M | $22M | $28M | $22M | |
| Total Liabilities | $1.22B | $535M | $543M | $527M | $120M | $110M | $111M | $114M | $91M | $107M | · | $101M | $93M | $165M | · | $234M | |
| Long-term Debt | $1.13B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $19.0K | $19.0K | $18.0K | · | $18.0K | $17.0K | $17.0K | · | $17.0K | |
| Paid-in Capital | $380M | $397M | $401M | $363M | $359M | $341M | $337M | $309M | $239M | $218M | · | $184M | $171M | $154M | · | $349M | |
| Retained Earnings | $583M | $595M | $608M | $578M | $461M | $457M | $499M | $530M | $537M | $589M | · | $485M | $495M | $493M | · | $468M | |
| AOCI | $4M | $5M | $8M | $9M | $8M | $-2M | $-6M | $2M | $-935.0K | $-910.0K | · | $-944.0K | $-967.0K | $-935.0K | · | $-1M | |
| Stockholders' Equity | $968M | $997M | $1.02B | $950M | $829M | $796M | $830M | $841M | $775M | $807M | $701M | $668M | $665M | $646M | $597M | $816M | |
| Liabilities + Equity | $2.19B | $1.53B | $1.56B | $1.48B | $949M | $905M | $942M | $955M | $866M | $914M | · | $769M | $758M | $811M | · | $1.05B | |
| Shares Outstanding | 19,920,000 | 20,029,000 | 19,774,000 | 19,656,000 | 19,411,000 | 19,276,000 | 19,106,000 | 18,760,000 | 18,103,000 | 17,924,000 | 17,556,000 | 17,421,000 | 17,352,000 | 17,134,000 | 16,951,000 | 16,894,000 |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $11M | $13M | |
| Stock-based Comp | $14M | $11M | $14M | $15M | $10M | $8M | $8M | $15M | $11M | $7M | $6M | $7M | $7M | $6M | $29M | $13M | |
| Other Non-cash | · | $43M | · | · | · | $400.0K | · | · | · | $-84M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $24M | $49M | $46M | $13M | $16M | $-25M | $28M | $37M | $13M | $19M | $8M | $8M | $-82.0K | $34M | $53M | $20M | |
| CapEx | $26.0K | $228.0K | $9.0K | $15.0K | $214.0K | $214.0K | $712.0K | $596.0K | $408.0K | $105.0K | $417.0K | $487.0K | $203.0K | $2M | $2M | $4M | |
| Investing Cash Flow | $321M | $-94M | $-18M | $-353M | $-11M | $5M | $-39M | $-47M | $-55M | $-4M | $-10M | $-20M | $8M | $11M | $-7M | $19M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $0 | · | · | · | $3M | · | · | · | $0 | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $15M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $546M | $-14M | $8M | $410M | $15M | $-5M | $20M | $55M | $9M | $12M | $5M | $3M | $-68M | $-775.0K | $-5M | $-41M | |
| Net Change in Cash | $892M | $-60M | · | · | $20M | $-24M | $9M | $45M | $-32M | $27M | $3M | $-9M | $-60M | $44M | $41M | $-1M | |
| Free Cash Flow | · | $48M | · | · | · | $-26M | · | · | · | $19M | · | · | · | $32M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $19M | · | · | · | $31M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.5% | 33.6% | · | 47.6% | 17.7% | -79.9% | · | 6.1% | -46.0% | 9.7% | · | 9.4% | -7.5% | 32.3% | · | 0.96% | |
| Net Margin | 76.2% | -25.8% | · | 101.6% | 10.2% | -93.6% | · | -13.8% | -125.0% | 278.1% | · | -31.3% | 8.7% | 95.4% | · | 0.61% | |
| Pretax Margin | 101.0% | -46.9% | · | 122.2% | 23.6% | -110.7% | · | -12.2% | -157.4% | 366.2% | · | -37.0% | 12.0% | 126.3% | · | 1.3% | |
| EBITDA Margin | 13.5% | 49.5% | · | 47.6% | 17.7% | -60.5% | · | 6.1% | -46.0% | 37.9% | · | 9.4% | -7.5% | 53.9% | · | 0.96% | |
| ROA | 3.1% | -1.1% | · | 9.7% | 0.53% | -4.7% | · | -0.83% | -6.4% | 10.0% | · | -1.1% | 0.25% | 4.4% | · | 0.03% | |
| ROE | 5.4% | -1.5% | · | 13.1% | 0.60% | -5.3% | · | -0.95% | -7.2% | 11.9% | · | -1.4% | 0.31% | 5.8% | · | 0.05% | |
| ROIC | 0.67% | 0.96% | · | 4.8% | 0.44% | -3.9% | · | 0.42% | -2.0% | 0.28% | · | 0.39% | -0.22% | 1.7% | · | 0.04% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.2 | 21.3 | · | 24.7 | 5.5 | 5.3 | · | 12.5 | 16.8 | 20.7 | · | 16.2 | 9.4 | 3.3 | · | 1.6 | |
| Quick Ratio | 30.5 | 20.5 | · | 23.6 | 4.4 | 4.2 | · | 10.3 | 14.2 | 19.0 | · | 14.4 | 8.4 | 3.2 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 21.2 | · | 3078.0 | -7.0 | 59.2 | · | 1.9 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.2 | 1.1 | · | 2.5 | 1.2 | 1.4 | · | 1.5 | 1.3 | 1.1 | · | 0.6 | 0.6 | 1.2 | · | 1.0 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $279M | $260M | · | $260M | $186M | $170M | · | $157M | $132M | $134M | · | $154M | $180M | $204M | · | $202M | |
| Net Income TTM | $157M | $66M | · | $72M | $-97M | $-15M | · | $17M | $26M | $120M | · | $16M | $27M | $24M | · | $-21M | |
| Market Cap | $6.30B | $4.00B | · | $3.48B | $2.21B | $2.03B | · | $1.88B | $1.53B | $1.31B | · | $1.04B | $1.25B | $1.26B | · | $908M | |
| P/E | 42.3 | 65.7 | · | 53.4 | -21.7 | -144.0 | · | 112.5 | 59.8 | 11.0 | · | 31.7 | 29.7 | 52.9 | · | -383.7 | |
| P/S | 22.6 | 15.4 | · | 13.4 | 11.8 | 11.9 | · | 11.9 | 11.6 | 9.8 | · | 6.8 | 7.0 | 6.2 | · | 4.5 | |
| P/B | 6.5 | 4.0 | · | 3.7 | 2.7 | 2.5 | · | 2.2 | 2.0 | 1.6 | · | 1.6 | 1.9 | 2.0 | · | 1.1 | |
| P / Tangible Book | 9.6 | 5.9 | · | 5.7 | 4.6 | 4.7 | · | 4.1 | 3.9 | 3.2 | · | 4.2 | 5.4 | 6.1 | · | 7.7 | |
| P / Cash Flow | · | 82.1 | · | · | · | -79.6 | · | · | · | 69.9 | · | · | · | 37.1 | · | · | |
| P / FCF | · | 82.5 | · | · | · | -79.0 | · | · | · | 70.3 | · | · | · | 40.0 | · | · | |
| Earnings Yield | 2.4% | 1.5% | · | 1.9% | -4.6% | -0.69% | · | 0.89% | 1.7% | 9.1% | · | 3.1% | 3.4% | 1.9% | · | -0.26% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $268M | $167M | $131M | $196M | $242M |
| Marża Operacyjna % | 15.3% | -13.5% | 9.1% | 1.6% | 28.5% |
| Zysk netto | $124M | $-4M | $52M | $-33M | $57M |
| Rozwodniony EPS | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 22.2 | 8.9 | 14.1 | 2.7 | 11.2 |
| Wskaźnik Szybkości | 21.2 | 7.9 | 12.1 | 2.5 | 10.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $49M | $95M | $46M | $120M | $70M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 444 emitenci · $4.3B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 105 (+43 vs poprzedni kw.) | 31 (-14 vs poprzedni kw.) | 137 (+17 vs poprzedni kw.) | 109 (-3 vs poprzedni kw.) | +2.6M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $359 810 304 | 1 138 316 | 8,40% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $275 298 586 | 870 950 | 6,42% | Akcje |
| STATE STREET CORP | $261 251 813 | 826 539 | 6,10% | Akcje |
| FMR LLC | $231 737 274 | 733 137 | 5,41% | Akcje |
| CONGRESS ASSET MANAGEMENT CO | $208 591 268 | 659 911 | 4,87% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $179 656 000 | 568 371 | 4,19% | Akcje |
| Chicago Capital, LLC | $174 935 212 | 553 435 | 4,08% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $162 860 291 | 515 140 | 3,80% | Akcje |
| Stephens Investment Management Group LLC | $150 335 249 | 475 609 | 3,51% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $129 680 348 | 410 264 | 3,03% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $118 774 611 | 375 762 | 2,77% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $116 953 300 | 3 700 | 2,73% | Opcja kupna |
| RICE HALL JAMES & ASSOCIATES, LLC | $85 360 737 | 270 052 | 1,99% | Akcje |
| Ranger Investment Management, L.P. | $81 423 520 | 257 596 | 1,90% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $80 212 263 | 253 764 | 1,87% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $78 452 590 | 248 197 | 1,83% | Akcje |
| LOOMIS SAYLES & CO L P | $76 697 342 | 242 644 | 1,79% | Akcje |
| NEXT CENTURY GROWTH INVESTORS LLC | $62 757 140 | 198 542 | 1,46% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $61 080 599 | 193 238 | 1,43% | Akcje |
| Private Capital Management, LLC | $52 475 997 | 166 016 | 1,22% | Akcje |
| VILLERE ST DENIS J & CO LLC | $49 153 891 | 155 506 | 1,15% | Akcje |
| Granahan Investment Management, LLC | $46 538 247 | 147 231 | 1,09% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $45 177 479 | 142 926 | 1,05% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $43 385 881 | 137 258 | 1,01% | Akcje |
| ASHFORD CAPITAL MANAGEMENT INC | $41 440 352 | 207 565 | 0,97% | Akcje |
| Impax Asset Management Group plc | $41 091 700 | 130 000 | 0,96% | Akcje |
| Fisher Asset Management, LLC | $38 386 026 | 121 440 | 0,90% | Akcje |
| Driehaus Capital Management LLC | $37 455 717 | 118 497 | 0,87% | Akcje |
| Penn Capital Management Company, LLC | $31 748 435 | 100 337 | 0,74% | Akcje |
| Aberdeen Group plc | $30 564 955 | 96 697 | 0,71% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $29 735 218 | 94 072 | 0,69% | Akcje |
| FIRST TRUST ADVISORS LP | $28 730 368 | 90 893 | 0,67% | Akcje |
| GOLDMAN SACHS GROUP INC | $25 743 318 | 81 443 | 0,60% | Akcje |
| VANGUARD GROUP INC | $23 737 549 | 125 549 | 0,55% | Akcje |
| AMERIPRISE FINANCIAL INC | $23 554 423 | 74 519 | 0,55% | Akcje |
| Public Sector Pension Investment Board | $21 774 808 | 68 888 | 0,51% | Akcje |
| CITIGROUP INC | $20 697 573 | 65 480 | 0,48% | Akcje |
| CASTLEARK MANAGEMENT LLC | $19 611 172 | 62 043 | 0,46% | Akcje |
| NOMURA HOLDINGS INC | $19 577 982 | 61 938 | 0,46% | Akcje |
| Dana Investment Advisors, Inc. | $18 181 497 | 57 520 | 0,42% | Akcje |
| D. E. Shaw & Co., Inc. | $17 863 826 | 56 515 | 0,42% | Akcje |
| JANUS HENDERSON GROUP PLC | $17 557 217 | 87 949 | 0,41% | Akcje |
| Granite Investment Partners, LLC | $17 109 320 | 54 128 | 0,40% | Akcje |
| RHUMBLINE ADVISERS | $15 843 977 | 50 125 | 0,37% | Akcje |
| Emerald Investment Advisers, LLC | $14 831 259 | 46 921 | 0,35% | Akcje |
| Context Capital Management, LLC | $14 540 140 | 46 000 | 0,34% | Akcje |
| PRUDENTIAL FINANCIAL INC | $14 389 365 | 45 523 | 0,34% | Akcje |
| SUSQUEHANNA ADVISORS GROUP, INC. | $14 097 614 | 44 600 | 0,33% | Akcje |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $14 076 120 | 44 532 | 0,33% | Akcje |
| WCM INVESTMENT MANAGEMENT, LLC | $13 996 763 | 44 570 | 0,33% | Akcje |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $13 771 093 | 43 567 | 0,32% | Akcje |
| BANK OF AMERICA CORP /DE/ | $13 748 019 | 43 494 | 0,32% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $12 754 231 | 40 350 | 0,30% | Akcje |
| Pembroke Management, LTD | $12 731 157 | 40 277 | 0,30% | Akcje |
| Swiss National Bank | $12 327 510 | 39 000 | 0,29% | Akcje |
| ARISTEIA CAPITAL, L.L.C. | $11 774 353 | 37 250 | 0,27% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $10 939 038 | 34 607 | 0,26% | Akcje |
| Congress Wealth Management LLC / DE / | $10 733 322 | 94 417 | 0,25% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10 699 962 | 33 851 | 0,25% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $10 542 550 | 33 353 | 0,25% | Akcje |
| Uniplan Investment Counsel, Inc. | $10 495 472 | 33 204 | 0,24% | Akcje |
| Clark Capital Management Group, Inc. | $10 414 533 | 32 948 | 0,24% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10 304 534 | 32 600 | 0,24% | Opcja sprzedaży |
| Legal & General Group Plc | $9 704 596 | 30 702 | 0,23% | Akcje |
| Moody Aldrich Partners LLC | $8 901 094 | 28 160 | 0,21% | Akcje |
| Linden Advisors LP | $8 669 084 | 27 426 | 0,20% | Akcje |
| Hodges Capital Management Inc. | $7 410 414 | 23 444 | 0,17% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $7 344 667 | 23 236 | 0,17% | Akcje |
| Squarepoint Ops LLC | $7 206 852 | 22 800 | 0,17% | Akcje |
| ISTHMUS PARTNERS, LLC | $6 617 344 | 20 935 | 0,15% | Akcje |
| Moran Wealth Management, LLC | $6 253 208 | 19 783 | 0,15% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $6 214 013 | 19 659 | 0,14% | Akcje |
| Informed Momentum Co LLC | $6 163 123 | 19 498 | 0,14% | Akcje |
| TD Waterhouse Canada Inc. | $6 121 719 | 19 625 | 0,14% | Akcje |
| PALISADE CAPITAL MANAGEMENT, LP | $6 023 727 | 19 057 | 0,14% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $5 950 394 | 18 825 | 0,14% | Akcje |
| Lisanti Capital Growth, LLC | $5 925 739 | 18 747 | 0,14% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $5 897 923 | 18 659 | 0,14% | Akcje |
| MORGAN STANLEY | $5 822 378 | 18 420 | 0,14% | Akcje |
| WOODSTOCK CORP | $5 798 671 | 18 345 | 0,14% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $5 551 173 | 17 562 | 0,13% | Akcje |
| Calamos Advisors LLC | $5 437 696 | 17 203 | 0,13% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $5 409 517 | 27 095 | 0,13% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 189 250 | 16 417 | 0,12% | Akcje |
| BlackRock, Inc. | $4 991 693 | 15 792 | 0,12% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 962 613 | 15 700 | 0,12% | Opcja kupna |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 748 476 | 23 784 | 0,11% | Akcje |
| Future Fund LLC | $4 647 787 | 14 704 | 0,11% | Akcje |
| OSAIC HOLDINGS, INC. | $4 253 131 | 13 456 | 0,10% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $4 020 665 | 12 720 | 0,09% | Akcje |
| NFJ INVESTMENT GROUP, LLC | $4 004 860 | 12 670 | 0,09% | Akcje |
| Quantinno Capital Management LP | $3 832 275 | 12 124 | 0,09% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 808 568 | 12 049 | 0,09% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $3 774 807 | 11 863 | 0,09% | Akcje |
| COOKSON PEIRCE & CO INC | $3 736 816 | 11 822 | 0,09% | Akcje |
| Corient Private Wealth LP | $3 697 924 | 11 699 | 0,09% | Akcje |
| MetLife Investment Management, LLC | $3 692 879 | 11 683 | 0,09% | Akcje |
| CONNORS INVESTOR SERVICES INC | $3 439 059 | 10 880 | 0,08% | Akcje |
| JANE STREET GROUP, LLC | $3 192 509 | 10 100 | 0,07% | Opcja kupna |
| CITADEL ADVISORS LLC | $3 160 900 | 10 000 | 0,07% | Opcja kupna |
Insiderzy spółki 47 insiderów · 16 dyrektorzy generalni · 22 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Todd C Davis | Chief Executive Officer | 30 czerwca 2026 J | 199 513 | 0 | 0 | $0 |
| David E Robinson | Pres, CEO & Chairman | 10 marca 2006 A | 411 725 | 0 | 0 | $0 |
| Nishan M Desilva | VP, Finance & Strategy and CFO | 14 maja 2015 M | 22 282 | 0 | 0 | $0 |
| John P Sharp | VP Finance and CFO | 12 lutego 2014 M | 17 667 | 0 | 0 | $0 |
| Paul V Maier | Sr. V-P, CFO | 20 listopada 2006 M | 84 951 | 0 | 0 | $0 |
| Matthew E Korenberg | PRESIDENT & CHIEF OPERATING | 30 czerwca 2023 J | 99 124 | 0 | 0 | $0 |
| Melanie J Herman | Director of Accounting | 30 czerwca 2016 J | 3 454 | 0 | 0 | $0 |
| Syed Kazmi | VP, Bus. Dev. & Strategic Plan | 9 lutego 2012 A | 18 230 | 0 | 0 | $0 |
| Martin Meglasson | V-P, Discovery Research | 11 maja 2010 P | 102 250 | 0 | 0 | $0 |
| Zofia E Dziewanowska | VP, Clinical Research | 25 lutego 2009 S | 33 977 | 0 | 0 | $0 |
| William A Petttit | Sr. V-P, HR and Administration | 15 grudnia 2006 M | 889 | 0 | 0 | $0 |
| Eric S Groves | V-P, Project Management | 15 grudnia 2006 M | 5 127 | 0 | 0 | $0 |
| Andres Negro-Vilar | Exe V-P, R & D, CSO | 14 grudnia 2006 M | 7 233 | 0 | 0 | $0 |
| Taylor Crouch | Sr. V-P, Ops & Pres. Int'l | 5 grudnia 2006 M | 0 | 0 | 0 | $0 |
| Tod Mertes | V-P, Controller & Treasurer | 10 marca 2006 A | 1 476 | 0 | 0 | $0 |
| James J Litalien | Sr. V-P, Reg Affairs & Comp. | 10 marca 2006 A | 0 | 0 | 0 | $0 |
| Stephen L Sabba | Dyrektor | 16 czerwca 2026 M | 33 629 | 0 | 3 | $-1 162 551 |
| John L Lamattina | Dyrektor | 10 czerwca 2026 S | 26 969 | 0 | 4 | $-1 151 786 |
| Martine Zimmermann | Dyrektor | 5 czerwca 2026 F | 5 097 | 0 | 0 | $0 |
| Nancy Ryan Gray | Dyrektor | 5 czerwca 2026 A | 8 930 | 0 | 0 | $0 |
| Jason Aryeh | Dyrektor | 5 czerwca 2026 A | 102 580 | 0 | 2 | $-1 250 000 |
| John W Kozarich | Dyrektor | 5 czerwca 2026 A | 42 622 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | Dyrektor | 17 grudnia 2025 A | 1 500 000 | 0 | 0 | $0 |
| John L Higgins | Dyrektor | 28 grudnia 2022 F | 417 695 | 0 | 0 | $0 |
| David M Knott | Dyrektor | 17 sierpnia 2015 S | 66 152 | 0 | 0 | $0 |
| Steven J Burakoff | Dyrektor | 29 maja 2009 A | 15 000 | 0 | 0 | $0 |
| Bruce Peacock | Dyrektor | 23 grudnia 2008 A | 10 000 | 0 | 0 | $0 |
| Jeffrey R Perry | Dyrektor | 29 maja 2008 A | 33 953 | 0 | 0 | $0 |
| Elizabeth M Greetham | Dyrektor | 29 maja 2008 A | 10 000 | 0 | 0 | $0 |
| Henry F Blissenbach | Dyrektor | 2 kwietnia 2007 M | 15 005 | 0 | 0 | $0 |
| Brigette Roberts | Dyrektor | 3 stycznia 2007 A | 2 378 | 0 | 0 | $0 |
| Irving S Johnson | Dyrektor | 3 stycznia 2007 A | 22 929 | 0 | 0 | $0 |
| Alexander D Cross | Dyrektor | 3 stycznia 2007 A | 26 335 | 0 | 0 | $0 |
| John Groom | Dyrektor | 27 września 2006 A | 16 237 | 0 | 0 | $0 |
| Carl C Peck | Dyrektor | 27 września 2006 A | 8 378 | 0 | 0 | $0 |
| Michael A Rocca | Dyrektor | 27 września 2006 A | 11 676 | 0 | 0 | $0 |
| Octavio Espinoza | — | 12 sierpnia 2026 M | 27 696 | 0 | 1 | $-9 241 070 |
| Jason Haas | — | 12 sierpnia 2026 M | 3 981 | 0 | 3 | $-3 741 401 |
| Andrew Reardon | — | 3 sierpnia 2026 M | 41 514 | 0 | 19 | $-3 121 290 |
| Jennifer R. Cochran | — | 1 listopada 2022 D | 1 161 | 0 | 0 | $0 |
| Sarah Boyce | — | 1 listopada 2022 D | 2 892 | 0 | 0 | $0 |
| Sunil Patel | — | 1 listopada 2022 D | 28 820 | 0 | 0 | $0 |
| Charles S Berkman | — | 1 listopada 2022 D | 23 825 | 0 | 0 | $0 |
| Matthew W Foehr | — | 1 listopada 2022 D | 162 187 | 0 | 0 | $0 |
| Loeb, Daniel S. | — | 26 marca 2007 S | 2 027 378 | 0 | 0 | $0 |
| Warner R Broaddus | — | 17 listopada 2006 M | 0 | 0 | 0 | $0 |
| Giambattista Aliprandi | — | 1 czerwca 2004 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 18 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated ×10 zgłoszenia | 1 maja 2026 | 47,00% | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| David M. Knott, Dorset Management Corporation ×8 zgłoszenia | 24 maja 2016 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| Ligand Pharmaceuticals Incorporated (2) ×4 zgłoszenia | 28 stycznia 2010 | — | Pierwotne zgłoszenie | — | SEC |
| Noonday Asset Management, L.P., Noonday G.P. (U.S.), L.L.C., Noonday Capital, L.L.C., David I. Cohen, Saurabh K. Mittal, Noonday Capital Partners, L.L.C., Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Tinicum Partners, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital Management, L.L.C., Farallon Partners, L.L.C., Chun R. Ding, William F. Duhamel, Richard B. Fried, Monica R. Landry, Douglas M. MacMahon, William F. Mellin, Stephen L. Millham, Jason E. Moment, Rajiv A. Patel, Derek C. Schrier, Thomas F. Steyer, Mark C. Wehrly | 30 marca 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 28 marca 2007 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 12 lutego 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 18 września 2006 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 10 sierpnia 2006 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 5 grudnia 2005 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 16 listopada 2005 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 7 listopada 2005 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 26 października 2005 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 12 października 2005 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 30 września 2005 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 23 września 2005 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 79 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3,17% | 54 706 SH | 8 sierpnia 2026 | Dziennie |
| PSCH · Invesco Exchange-Traded Fund Trust … | 2,97% | 17 394 SH | 8 sierpnia 2026 | Dziennie |
| ALIL · EA Series Trust | 2,16% | 2 385 NS | 29 maja 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,93% | 4 992 NS | 30 kwietnia 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 1,88% | 198 917 SH | 8 sierpnia 2026 | Dziennie |
| PTH · Invesco Exchange-Traded Fund Trust | 1,71% | 14 387 SH | 8 sierpnia 2026 | Dziennie |
| PILL · Direxion Shares ETF Trust | 1,39% | 780 NS | 30 kwietnia 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 1,33% | 1 317 NS | 30 kwietnia 2026 | N-PORT |
| IHE · iShares Trust | 1,33% | 71 583 SH | 8 sierpnia 2026 | Dziennie |
| RZG · Invesco Exchange-Traded Fund Trust | 1,12% | 5 313 SH | 8 sierpnia 2026 | Dziennie |
| GSC · Goldman Sachs ETF Trust | 1,04% | 11 355 NS | 31 maja 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,82% | 1 851 NS | 31 maja 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,69% | 23 854 SH | 8 sierpnia 2026 | Dziennie |
| IJT · iShares Trust | 0,67% | 186 107 SH | 8 sierpnia 2026 | Dziennie |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,63% | 483 SH | 8 sierpnia 2026 | Dziennie |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,51% | 23 394 NS | 30 kwietnia 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,44% | 6 688 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,40% | 1 093 SH | 8 sierpnia 2026 | Dziennie |
| XJR · iShares Trust | 0,38% | 2 375 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,37% | 182 189 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,37% | 21 495 SH | 8 sierpnia 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,34% | 70 067 SH | 8 sierpnia 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,34% | 2 941 SH | 8 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | 0,33% | 1 222 161 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,32% | 38 029 NS | 31 maja 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 8 095 NS | 30 kwietnia 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,26% | 13 910 NS | 30 kwietnia 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,26% | 2 424 NS | 31 maja 2026 | N-PORT |
| BIB · ProShares Trust | 0,23% | 736 NS | 31 maja 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 6 966 NS | 30 kwietnia 2026 | N-PORT |
| SAA · ProShares Trust | 0,20% | 236 NS | 31 maja 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,20% | 702 NS | 30 kwietnia 2026 | N-PORT |
| SMLF · iShares Trust | 0,20% | 27 794 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,19% | 115 596 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,19% | 509 128 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,19% | 7 952 NS | 31 maja 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,15% | 15 366 NS | 30 kwietnia 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,14% | 597 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,14% | 8 429 NS | 30 kwietnia 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,13% | 277 215 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,12% | 3 926 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,11% | 912 NS | 31 maja 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 2 180 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 10 188 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,10% | 60 435 NS | 30 kwietnia 2026 | N-PORT |
| SMMV · iShares Trust | 0,10% | 934 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,10% | 94 556 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,09% | 887 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,09% | 58 421 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 9 071 NS | 30 kwietnia 2026 | N-PORT |